Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Village Super Market
VLGEA
$627M
| $13.3M | 0.02% |
503,400
-3,100
| -0.6% | -$90.1K |
|
|
RAS
1052
DELISTED
RAIT Financial Trust
RAS
| $13.3M | 0.02% |
4,163,100
+511,400
| +14% | +$1.74M |
|
1053
Western New England Bancorp
WNEB
$282M
| $13.3M | 0.02% |
1,264,909
+91,679
| +8% | +$902K |
|
|
SNCR
1054
DELISTED
Synchronoss Technologies
SNCR
| $13.3M | 0.02% |
60,433
+52,244
| +638% | +$15.2M |
|
|
COTV
1055
DELISTED
Cotiviti Holdings, Inc.
COTV
| $13.3M | 0.02% |
+318,500
| New | +$11.6M |
|
1056
Fidelity National Financial
FNF
$12.8B
| $13.3M | 0.02% |
490,190
-2,093,045
| -81% | -$53.3M |
|
1057
PJT Partners
PJT
$4.36B
| $13.2M | 0.02% |
377,200
+92,100
| +32% | +$3.19M |
|
|
FMBI
1058
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $13.2M | 0.02% |
558,171
+22,400
| +4% | +$545K |
|
1059
Apple Hospitality REIT
APLE
$3.71B
| $13.2M | 0.02% |
690,235
+331,535
| +92% | +$6.54M |
|
1060
ASE Group
ASX
$102B
| $13.2M | 0.02% |
2,031,779
+21,200
| +1% | +$126K |
|
1061
Vanda Pharmaceuticals
VNDA
$314M
| $13.2M | 0.02% |
939,250
+370,900
| +65% | +$5.29M |
|
1062
Hooker Furnishings Corp
HOFT
$160M
| $13.1M | 0.02% |
423,327
+24,962
| +6% | +$826K |
|
|
BV
1063
DELISTED
Bazaarvoice, Inc.
BV
| $13.1M | 0.02% |
3,046,700
+119,700
| +4% | +$538K |
|
1064
iShares MSCI Emerging Markets ETF
EEM
$30.4B
| $13.1M | 0.02% |
332,100
+137,700
| +71% | +$5.23M |
|
|
TMHC
1065
DELISTED
Taylor Morrison
TMHC
| $13M | 0.02% |
610,100
+585,200
| +2,350% | +$11.8M |
|
1066
A.O. Smith
AOS
$8.51B
| $13M | 0.02% |
+254,200
| New | +$12.6M |
|
|
UBA
1067
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $13M | 0.02% |
632,100
+121,300
| +24% | +$2.68M |
|
|
DCOM
1068
DELISTED
Dime Community Bancshares
DCOM
| $13M | 0.02% |
640,072
+30,447
| +5% | +$634K |
|
1069
Liquidity Services
LQDT
$1.35B
| $13M | 0.02% |
1,623,999
+171,200
| +12% | +$1.5M |
|
|
GNCMA
1070
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $13M | 0.02% |
623,500
+32,600
| +6% | +$654K |
|
1071
Wintrust Financial
WTFC
$11B
| $13M | 0.02% |
187,400
+128,500
| +218% | +$9.23M |
|
1072
WPP
WPP
$5.8B
| $13M | 0.02% |
118,395
+44,066
| +59% | +$4.95M |
|
|
FFNW
1073
DELISTED
First Financial Northwest, Inc
FFNW
| $12.9M | 0.02% |
731,100
+77,693
| +12% | +$1.52M |
|
|
CACB
1074
DELISTED
Cascade Bancorp
CACB
| $12.9M | 0.02% |
1,674,081
-168,426
| -9% | -$1.34M |
|
|
HMSY
1075
DELISTED
HMS Holdings Corp.
HMSY
| $12.9M | 0.02% |
634,512
-201,188
| -24% | -$3.71M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.